Concepedia

Zengjun Li

ZL

48

Publications

1.4K

Citations

23

H-Index

2010

Active since

Affiliations

Institute of Hematology & Blood Diseases Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Shandong First Medical University

Shandong Tumor Hospital

Henan Cancer Hospital

Zengjun Li is an author at Institute of Hematology & Blood Diseases Hospital specializing in pathology, medicine, and oncology.

ORCID

Top concepts

Publications per year

2010–2024

48

Publications

48

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study

Wei Xu, Shenmiao Yang, Keshu Zhou et al. · Journal of Hematology & Oncology · 2020 · 128 citations · Full text

The Impact of Clone Size on the Prognostic Value of Chromosome Aberrations by Fluorescence <i>In Situ</i> Hybridization in Multiple Myeloma

Gang An, Zengjun Li, Yu‐Tzu Tai et al. · Clinical Cancer Research · 2015 · 89 citations

Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study

Jianping Wang, Side Liu, Hui Wang et al. · Clinical Epigenetics · 2020 · 84 citations · Full text

Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients

Gang An, Xiaoqi Qin, Chirag Acharya et al. · Annals of Hematology · 2014 · 70 citations

, , +9

Hedgehog pathway is involved in nitidine chloride induced inhibition of epithelial-mesenchymal transition and cancer stem cells-like properties in breast cancer cells

Mingjuan Sun, Ning Zhang, Xiaolong Wang et al. · Cell & Bioscience · 2016 · 68 citations · Full text

Rows per page

1–5 of 48